Targacept Scientists to Present at Neuroscience 2012
[at noodls] – Winston-Salem, NC October 11, 2012 Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics â„¢, today announced that its scientists are scheduled to make … more
View todays social media effects on TRGT
View the latest stocks trending across Twitter. Click to view dashboard